Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endothelial Cells | 8 | 2014 | 57 | 1.280 |
Why?
|
| Endothelium, Vascular | 6 | 2010 | 47 | 1.100 |
Why?
|
| Catenins | 2 | 2011 | 3 | 0.720 |
Why?
|
| Capillary Permeability | 4 | 2006 | 28 | 0.600 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2007 | 24 | 0.590 |
Why?
|
| Lysophosphatidylcholines | 3 | 2007 | 7 | 0.580 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 5 | 2004 | 32 | 0.530 |
Why?
|
| Signal Transduction | 7 | 2014 | 410 | 0.460 |
Why?
|
| rhoA GTP-Binding Protein | 2 | 2005 | 8 | 0.460 |
Why?
|
| Up-Regulation | 2 | 2012 | 150 | 0.440 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2004 | 46 | 0.410 |
Why?
|
| Cells, Cultured | 9 | 2010 | 495 | 0.340 |
Why?
|
| Transcription Factors | 2 | 2010 | 158 | 0.340 |
Why?
|
| Promoter Regions, Genetic | 3 | 2012 | 89 | 0.300 |
Why?
|
| Carrier Proteins | 3 | 2004 | 96 | 0.290 |
Why?
|
| Receptors, Lysophospholipid | 1 | 2007 | 2 | 0.280 |
Why?
|
| Monocytes | 1 | 2007 | 53 | 0.270 |
Why?
|
| Protein Kinase C | 1 | 2005 | 50 | 0.240 |
Why?
|
| Gene Expression Regulation | 4 | 2012 | 262 | 0.240 |
Why?
|
| Brain | 4 | 2011 | 1560 | 0.230 |
Why?
|
| RNA, Small Interfering | 4 | 2012 | 72 | 0.200 |
Why?
|
| Animals | 9 | 2010 | 3510 | 0.190 |
Why?
|
| Isoenzymes | 1 | 2002 | 51 | 0.190 |
Why?
|
| High Mobility Group Proteins | 1 | 2001 | 2 | 0.190 |
Why?
|
| Thrombin | 3 | 2014 | 13 | 0.190 |
Why?
|
| Transcription, Genetic | 2 | 2011 | 100 | 0.180 |
Why?
|
| Cyclic AMP | 4 | 2004 | 29 | 0.170 |
Why?
|
| Cattle | 3 | 2010 | 118 | 0.160 |
Why?
|
| Pulmonary Artery | 3 | 2011 | 43 | 0.160 |
Why?
|
| Cell Line | 3 | 2011 | 268 | 0.150 |
Why?
|
| Humans | 13 | 2014 | 25692 | 0.140 |
Why?
|
| Gene Silencing | 2 | 2011 | 23 | 0.140 |
Why?
|
| Inflammation | 2 | 2011 | 261 | 0.140 |
Why?
|
| Gene Expression | 3 | 2006 | 182 | 0.120 |
Why?
|
| Retina | 1 | 2014 | 8 | 0.120 |
Why?
|
| Diabetic Retinopathy | 1 | 2014 | 5 | 0.120 |
Why?
|
| Dermis | 2 | 2006 | 9 | 0.110 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2012 | 8 | 0.110 |
Why?
|
| Electric Impedance | 2 | 2005 | 20 | 0.110 |
Why?
|
| rac1 GTP-Binding Protein | 2 | 2005 | 13 | 0.110 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2012 | 34 | 0.110 |
Why?
|
| NF-kappa B | 1 | 2014 | 96 | 0.110 |
Why?
|
| MicroRNAs | 1 | 2014 | 52 | 0.110 |
Why?
|
| Skin | 2 | 2005 | 99 | 0.110 |
Why?
|
| Genistein | 1 | 2012 | 3 | 0.100 |
Why?
|
| Phytoestrogens | 1 | 2012 | 4 | 0.100 |
Why?
|
| Aorta | 1 | 2012 | 15 | 0.100 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2011 | 12 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 118 | 0.090 |
Why?
|
| Neutrophils | 1 | 2011 | 89 | 0.090 |
Why?
|
| Trans-Activators | 1 | 2010 | 23 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 35 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2010 | 36 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2007 | 133 | 0.080 |
Why?
|
| Hemostatics | 2 | 2014 | 9 | 0.080 |
Why?
|
| Adenoviridae | 3 | 2004 | 15 | 0.080 |
Why?
|
| Models, Biological | 1 | 2011 | 311 | 0.080 |
Why?
|
| Enzyme Activation | 2 | 2005 | 108 | 0.070 |
Why?
|
| Cell Survival | 2 | 2005 | 110 | 0.070 |
Why?
|
| Myosin Light Chains | 1 | 2007 | 3 | 0.070 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2007 | 4 | 0.070 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2007 | 7 | 0.070 |
Why?
|
| Retroviridae | 1 | 2007 | 5 | 0.070 |
Why?
|
| Luminescent Measurements | 1 | 2007 | 19 | 0.070 |
Why?
|
| Phosphorylation | 4 | 2012 | 134 | 0.070 |
Why?
|
| Mutagenesis | 1 | 2006 | 11 | 0.070 |
Why?
|
| COS Cells | 1 | 2006 | 37 | 0.060 |
Why?
|
| Electric Conductivity | 1 | 2006 | 66 | 0.060 |
Why?
|
| Guanosine Triphosphate | 1 | 2005 | 4 | 0.060 |
Why?
|
| Protein Kinase C-alpha | 1 | 2005 | 8 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2004 | 56 | 0.060 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2005 | 7 | 0.060 |
Why?
|
| Sphingosine | 1 | 2005 | 2 | 0.060 |
Why?
|
| Phosphorylcholine | 1 | 2005 | 4 | 0.060 |
Why?
|
| Mutation | 1 | 2007 | 325 | 0.060 |
Why?
|
| Protein Transport | 1 | 2005 | 29 | 0.060 |
Why?
|
| Rabbits | 2 | 2004 | 184 | 0.060 |
Why?
|
| Neovascularization, Physiologic | 1 | 2005 | 19 | 0.060 |
Why?
|
| Colforsin | 1 | 2004 | 11 | 0.060 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2004 | 5 | 0.060 |
Why?
|
| Rolipram | 1 | 2004 | 3 | 0.060 |
Why?
|
| Isoquinolines | 1 | 2004 | 12 | 0.060 |
Why?
|
| Adenosine Monophosphate | 1 | 2004 | 6 | 0.060 |
Why?
|
| Albuterol | 1 | 2004 | 14 | 0.060 |
Why?
|
| Lung | 1 | 2005 | 159 | 0.060 |
Why?
|
| Sulfonamides | 1 | 2004 | 40 | 0.060 |
Why?
|
| Epithelial Cells | 1 | 2004 | 72 | 0.050 |
Why?
|
| Myocytes, Cardiac | 1 | 2004 | 91 | 0.050 |
Why?
|
| Ion Channels | 1 | 2004 | 206 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 41 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 249 | 0.050 |
Why?
|
| Vascular Resistance | 1 | 2002 | 10 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2002 | 32 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2001 | 10 | 0.050 |
Why?
|
| Introns | 1 | 2001 | 16 | 0.050 |
Why?
|
| Luciferases | 1 | 2001 | 26 | 0.050 |
Why?
|
| Exons | 1 | 2001 | 29 | 0.050 |
Why?
|
| Base Sequence | 1 | 2001 | 90 | 0.050 |
Why?
|
| Transfection | 1 | 2001 | 112 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2001 | 111 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2001 | 169 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2002 | 284 | 0.050 |
Why?
|
| Serine | 2 | 2012 | 9 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2002 | 383 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 30 | 0.030 |
Why?
|
| Rats | 2 | 2007 | 649 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2005 | 68 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2012 | 36 | 0.030 |
Why?
|
| Binding Sites | 1 | 2012 | 65 | 0.030 |
Why?
|
| Protein Phosphatase 2 | 1 | 2007 | 2 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2007 | 7 | 0.020 |
Why?
|
| p21-Activated Kinases | 1 | 2007 | 8 | 0.020 |
Why?
|
| Swine | 1 | 2007 | 71 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2005 | 2 | 0.020 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2005 | 3 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2005 | 11 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2005 | 14 | 0.020 |
Why?
|
| Lysophospholipids | 1 | 2005 | 3 | 0.020 |
Why?
|
| Cell Division | 1 | 2005 | 79 | 0.020 |
Why?
|
| Antibodies | 1 | 2005 | 48 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2005 | 41 | 0.010 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2004 | 1 | 0.010 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 2004 | 5 | 0.010 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 1 | 2004 | 4 | 0.010 |
Why?
|
| Sarcolemma | 1 | 2004 | 7 | 0.010 |
Why?
|
| Diterpenes | 1 | 2004 | 4 | 0.010 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2004 | 6 | 0.010 |
Why?
|
| Isoproterenol | 1 | 2004 | 12 | 0.010 |
Why?
|
| Cell Movement | 1 | 2005 | 70 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2005 | 71 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2004 | 98 | 0.010 |
Why?
|
| Feedback | 1 | 2004 | 33 | 0.010 |
Why?
|
| Kinetics | 1 | 2004 | 179 | 0.010 |
Why?
|
| Activating Transcription Factor 1 | 1 | 2004 | 1 | 0.010 |
Why?
|
| Tritium | 1 | 2004 | 8 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 201 | 0.010 |
Why?
|
| Dinoprostone | 1 | 2004 | 16 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 2004 | 14 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2004 | 36 | 0.010 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2004 | 16 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2004 | 25 | 0.010 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 2002 | 2 | 0.010 |
Why?
|
| Lymphokines | 1 | 2002 | 7 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2002 | 12 | 0.010 |
Why?
|
| Endothelial Growth Factors | 1 | 2002 | 8 | 0.010 |
Why?
|
| Threonine | 1 | 2002 | 10 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 2002 | 8 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 31 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2002 | 52 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2002 | 149 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2002 | 51 | 0.010 |
Why?
|